Inovalon Holdings Inc (NASDAQ:INOV) has been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $12.00.
Several equities analysts have recently commented on INOV shares. BidaskClub downgraded Inovalon from a “sell” rating to a “strong sell” rating in a research report on Thursday, December 14th. Zacks Investment Research downgraded Inovalon from a “hold” rating to a “sell” rating in a research report on Wednesday, January 10th.
In other news, insider Shauna L. Vernal sold 5,908 shares of Inovalon stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $16.01, for a total value of $94,587.08. Following the sale, the insider now directly owns 47,309 shares of the company’s stock, valued at $757,417.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Robert A. Wychulis sold 85,828 shares of Inovalon stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $15.54, for a total value of $1,333,767.12. Following the completion of the sale, the president now directly owns 466,286 shares in the company, valued at $7,246,084.44. The disclosure for this sale can be found here. Insiders sold 136,006 shares of company stock worth $2,048,134 over the last ninety days. Insiders own 48.28% of the company’s stock.
Inovalon (INOV) opened at $12.50 on Friday. Inovalon has a 52-week low of $10.45 and a 52-week high of $17.80. The company has a market capitalization of $1,808.81, a PE ratio of 104.18, a PEG ratio of 3.05 and a beta of 0.94. The company has a debt-to-equity ratio of 0.31, a current ratio of 5.62 and a quick ratio of 5.62.
ILLEGAL ACTIVITY WARNING: “Inovalon Holdings Inc (INOV) Given Consensus Rating of “Hold” by Brokerages” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/02/10/inovalon-holdings-inc-inov-given-consensus-rating-of-hold-by-brokerages.html.
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.